Top compounds associated with response to CTSD


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib UHNBreast pan-cancer AAC 0.26 0.4
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.031 0.4
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.035 0.4
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC -0.034 0.4
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC 0.034 0.4
mRNA tivozanib CTRPv2 pan-cancer AAC -0.031 0.4
mRNA ML312 CTRPv2 pan-cancer AAC 0.063 0.4
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.4
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.045 0.4
Download CSV